We are live on ! Find out more
BIA

Biondo Investment Advisors Portfolio holdings

AUM $780M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
+4.87%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.37%
AUM
$422M
AUM Growth
+$23.2M
Cap. Flow
+$12.1M
Cap. Flow %
2.88%
Top 10 Hldgs %
50.61%
Holding
90
New
9
Increased
55
Reduced
20
Closed
2

Top Buys

Rank Stock Value
1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$6.31M
2
TEAM icon
Atlassian
TEAM
+$3.94M
3
SIVB
SVB Financial Group
SIVB
+$3.18M
4
TFC icon
Truist Financial
TFC
+$2.76M
5
BABA icon
Alibaba
BABA
+$1.68M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$7.88M
2
MA icon
Mastercard
MA
+$1.81M
3
DD icon
DuPont de Nemours
DD
+$932K
4
AAPL icon
Apple
AAPL
+$791K
5
IDXX icon
Idexx Laboratories
IDXX
+$596K

Sector Composition

Rank Sector Weight
1 Healthcare 37%
2 Technology 17.07%
3 Financials 13.73%
4 Consumer Discretionary 8.79%
5 Communication Services 5.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SWAV
76
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$528K 0.13%
+9,250
New +$449K
ET icon
77
Energy Transfer Partners
ET
$69.8B
$429K 0.1%
30,460
-3,000
-9% -$44.4K
BAC icon
78
Bank of America
BAC
$438B
$371K 0.09%
12,800
-3,650
-22% -$105K
SBBX
79
DELISTED
SB One Bancorp Common Stock
SBBX
$369K 0.09%
16,499
– –
KTB icon
80
Kontoor Brands
KTB
$4.68B
$346K 0.08%
+12,362
New +$367K
REGN icon
81
Regeneron Pharmaceuticals
REGN
$78.2B
$329K 0.08%
1,050
-23,682
-96% -$7.88M
VEEV icon
82
Veeva Systems
VEEV
$33.5B
$324K 0.08%
+2,000
New +$291K
V icon
83
Visa
V
$683B
$287K 0.07%
1,650
– –
MCI
84
Barings Corporate Investors
MCI
$337M
$235K 0.06%
15,000
– –
BLUE
85
DELISTED
bluebird bio
BLUE
$216K 0.05%
131
– –
BCPC
86
Balchem Corp
BCPC
$5.58B
$200K 0.05%
+2,000
New +$194K
GCVRZ
87
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$6K ﹤0.01%
10,800
-1,825
-14% -$911
PNC icon
88
PNC Financial Services
PNC
$100B
– –
-2,207
Closed -$271K
PNRG icon
89
PrimeEnergy Resources
PNRG
$300M
– –
-2,000
Closed -$285K
1 2 3
4

Similar funds

LA
Lifeworks Advisors Grand Rapids, Michigan $779M AUM 21.25% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return
RTM
RH Tailwind Management West Conshohocken, Pennsylvania $781M AUM
TCMX
Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return
QCMNJ
Quantum Capital Management (New Jersey) Northfield, New Jersey $781M AUM 4.96% 1-Year Est. Return
TIS
Titan Investment Solutions London $781M AUM
MO
McMillan Office St. Clair Shores, Michigan $782M AUM
NCM
Nellore Capital Management Redwood City, California $783M AUM 2.58% 1-Year Est. Return

Biondo Investment Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Biondo Investment Advisors held 90 positions worth $422M, up 5.8% from $399M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Biondo Investment Advisors's Q2 2019 filing shows 9 new, 55 increased, 20 reduced and 2 closed positions. Its largest new stake was Reata Pharmaceuticals, Inc. Class A Common Stock: 73,090 shares worth $6.9M. The largest sale was Regeneron Pharmaceuticals, an estimated $7.88M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 38% a quarter earlier, followed by Technology and Financials.

  • Biondo Investment Advisors's largest Q2 2019 buy was Reata Pharmaceuticals, Inc. Class A Common Stock: 73,090 shares worth $6.9M.
  • Biondo Investment Advisors added most to Atlassian in Q2 2019, an estimated $3.94M increase.
  • Biondo Investment Advisors's biggest Q2 2019 reduction was Regeneron Pharmaceuticals, cutting an estimated $7.88M.
  • Biondo Investment Advisors fully exited PrimeEnergy Resources in Q2 2019, selling an estimated $285K.
  • Biondo Investment Advisors's ten largest holdings make up 51% of its $422M portfolio in Q2 2019.
  • Biondo Investment Advisors opened 9 new positions and closed 2 in Q2 2019.
  • Biondo Investment Advisors's portfolio value rose 5.8% quarter-over-quarter to $422M.

Based on Biondo Investment Advisors's 13F filing for Q2 2019, filed 6 Aug 2019.